Oxytocin selectively reduces blood flow in uterine fibroids without an effect on myometrial blood flow: a dynamic contrast enhanced MRI evaluation

References

• Stewart EA, Cookson CL, Gandolfo RA, et al. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017;124(10):1501–1512.
   PubMed Web of Science ®Google Scholar
• Laughlin-Tommaso SK. Non-surgical management of myomas. J Minim Invasive Gynecol. 2018;25(2):229–236.
   PubMed Web of Science ®Google Scholar
• Silberzweig JE, Powell DK, Matsumoto AH, et al. Management of uterine fibroids: a focus on uterine-sparing interventional techniques. Radiology. 2016;280(3):675–692.
   PubMed Web of Science ®Google Scholar
• Rueff LE, Raman SS. Clinical and technical aspects of MR-guided high intensity focused ultrasound for treatment of symptomatic uterine fibroids. Semin Intervent Radiol. 2013;30(4):347–353.
   PubMed Web of Science ®Google Scholar
• Keserci B, Duc NM. Magnetic resonance imaging parameters in predicting the treatment outcome of high-intensity focused ultrasound ablation of uterine fibroids with an immediate nonperfused volume ratio of at least 90%. Acad Radiol. 2018;25(10):1257–1269.
   PubMed Web of Science ®Google Scholar
• Andrews S, Yuan Q, Bailey A, et al. Multiparametric MRI characterization of funaki types of uterine fibroids considered for MR-guided high-intensity focused ultrasound (MR-HIFU) therapy. Acad Radiol. 2019;26(4):e9–e17.
   PubMedGoogle Scholar
• Funaki K, Fukunishi H, Sawada K. Clinical outcomes of magnetic resonance-guided focused ultrasound surgery for uterine myomas: 24-month follow-up. Ultrasound Obstet Gynecol. 2009;34(5):584–589.
   PubMed Web of Science ®Google Scholar
• Zhao WP, Chen JY, Chen WZ. Effect of biological characteristics of different types of uterine fibroids, as assessed with t2-weighted magnetic resonance imaging, on ultrasound-guided high-intensity focused ultrasound ablation. Ultrasound Med Biol. 2015;41(2):423–431.
   PubMed Web of Science ®Google Scholar
• Lozinski T, Filipowska J, Krol P, et al. Oxytocin administration in high-intensity focused ultrasound treatment of myomata. Biomed Res Int. 2018;2018:1–5.
   Web of Science ®Google Scholar
• Lee HJ, Macbeth AH, Pagani JH, et al. Oxytocin: the great facilitator of life. Prog Neurobiol. 2009;88(2):127–151.
   PubMed Web of Science ®Google Scholar
• Engel S, Klusmann H, Ditzen B, et al. Menstrual cycle-related fluctuations in oxytocin concentrations: a systematic review and meta-analysis. Front Neuroendocrinol. 2019;52:144–155.
   PubMed Web of Science ®Google Scholar
• Gimpl G, Fahrenholz F, Gene C. The oxytocin receptor system: structure, function, and regulation. Physiol Rev. 2001;81(2):629–683.
   PubMed Web of Science ®Google Scholar
• Lee KH, Khan-Dawood FS, Dawood MY. Oxytocin receptor and its messenger ribonucleic acid in human leiomyoma and myometrium. Am J Obstet Gynecol. 1998;179(3):620–627.
   PubMed Web of Science ®Google Scholar
• Fu Y, Feng Q, Zhang S, et al. Application of oxytocin in ultrasound-guided percutaneous microwave ablation for treatment of hypervascular uterine fibroids: a preliminary report. Int J Hyperth. 2019;36(1):761–767.
   PubMed Web of Science ®Google Scholar
• Atashkhoei S, Fakhari S, Pourfathi H, et al. Effect of oxytocin infusion on reducing the blood loss during abdominal myomectomy: a double-blind randomised controlled trial. BJOG: Int J Obstet Gy. 2017;124(2):292–298.
   PubMed Web of Science ®Google Scholar
• Wang Y, Ren D, Wang W. The influence of oxytocin on the blood perfusion of uterine fibroids: contrast-enhanced ultrasonography evaluation. J Med Ultrasound. 2016;24(1):13–17.
   Web of Science ®Google Scholar
• Østergaard L, Weisskoff RM, Chesler DA, et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: mathematical approach and statistical analysis. Magn Reson Med. 1996;36(5):715–725.
   PubMed Web of Science ®Google Scholar
• Fleischer R, Weston GC, Vollenhoven BJ, et al. Pathophysiology of fibroid disease: angiogenesis and regulation of smooth muscle proliferation. Best Pract Res Clin Obstet Gynaecol. 2008;22(4):603–614.
   PubMed Web of Science ®Google Scholar
• Nieuwenhuis LL, Keizer AL, Stoelinga B, et al. Fibroid vascularisation assessed with three-dimensional power Doppler ultrasound is a predictor for uterine fibroid growth: a prospective cohort study. BJOG. 2018;125(5):577–584.
   PubMed Web of Science ®Google Scholar
• Sendemir A, Sendemir E, Kosmehl H, et al. Expression of sex hormone-binding globulin, oxytocin receptor, caveolin-1 and p21 in leiomyoma. Gynecol Endocrinol. 2008;24(2):105–112.
   PubMed Web of Science ®Google Scholar
• Bulun SE, Moravek MB, Yin P, et al. Uterine leiomyoma stem cells: linking progesterone to growth. Semin Reprod Med. 2015;33(5):357–365.
   PubMed Web of Science ®Google Scholar
• Rosseland LA, Hauge TH, Grindheim G, et al. Changes in blood pressure and cardiac output during cesarean delivery: the effects of oxytocin and carbetocin compared with placebo. Anesthesiology. 2013;119(3):541–551.
   PubMed Web of Science ®Google Scholar
• Meylaerts LJ, Wijnen L, Bazot M, et al. Perfusion of the uterine junctional zone in nulliparous and primiparous women assessed by DCE-MRI, as a function of menstrual cycle and hormonal contraception. Magn Reson Imaging. 2017;38:101–111.
   PubMed Web of Science ®Google Scholar
• Zhang R, Shi H, Ren F, et al. Assessment of carboprost tromethamine for reducing hemorrhage in laparoscopic intramural myomectomy. Exp Ther Med. 2015;10(3):1171–1174.
   PubMed Web of Science ®Google Scholar
• Wang C-J, Lee C-L, Yuen L-T, et al. Oxytocin infusion in laparoscopic myomectomy may decrease operative blood loss. J Minim Invasive Gynecol. 2007;14(2):184–188.
   PubMed Web of Science ®Google Scholar
• Jeong J-H, Hong GP, Kim Y-R, et al. Clinical consideration of treatment to ablate uterine fibroids with magnetic resonance imaging-guided high intensity focused ultrasound (MRgFUS): sonalleve. J Menopausal Med. 2016;22(2):94–107.
   PubMedGoogle Scholar